On 14 May 2013, the famous actress Angelina Jolie announced to the world that she had undergone prophylactic mastectomy (followed by a laparoscopic bilateral salpingo-oophorectomy), because she had been identified as the carrier of a BRCA1 gene mutation. The aim of our review was to explore the impact of the “Angelina Jolie Effect” on women.
Troiano, G., Cozzolino, M., Bagnoli, A., Nante, N. (2017). The "Angelina Jolie effect". EUROPEAN JOURNAL OF PUBLIC HEALTH, 27(Supplemento 3), 460-460 [10.1093/eurpub/ckx186.170].
The "Angelina Jolie effect"
Troiano, G.;Nante, N.
2017-01-01
Abstract
On 14 May 2013, the famous actress Angelina Jolie announced to the world that she had undergone prophylactic mastectomy (followed by a laparoscopic bilateral salpingo-oophorectomy), because she had been identified as the carrier of a BRCA1 gene mutation. The aim of our review was to explore the impact of the “Angelina Jolie Effect” on women.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
726.pdf
non disponibili
Descrizione: Free full-text sul sito dell'editore
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.1 MB
Formato
Adobe PDF
|
1.1 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1036265